{"product_id":"hpm-5001","title":"Anti-Helicobacter Pylori Cag Antigen, IgG Fraction, Monoclonal","description":"\u003cp\u003eIgG fraction from a mouse monoclonal antibody obtained by immunization of highly purified H. pylori Cag antigen (Clone 8C6\/F13).It recognizes the Cag protein in a H. pylori extract.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e Reacts in ELISA and Western blot (1:10,000 - 1:15,000 dilution).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS(pH 7.4)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpm-5001\"\u003ePublications using Austral Biologicals HPM-5001-5\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HPM-5001-5:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.gastha.2025.100860\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori Exploit Short-Chain Fatty Acids-Induced CAPZA1 Overexpression to Emerge CD44v9-Positive Stemness\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTsugawa et al., Gastro Hep Adv 5(3):100860 (2026).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12935-021-02140-2\" rel=\"noopener\" target=\"_blank\"\u003eNF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSoutto et al., Cancer Cell Int 21(1):444 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.15252\/embr.202152878\" rel=\"noopener\" target=\"_blank\"\u003eTIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMaubach et al., EMBO Rep 22(9):e52878 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s42003-020-0855-y\" rel=\"noopener\" target=\"_blank\"\u003eCholesteryl α-D-glucoside 6-acyltransferase enhances the adhesion of Helicobacter pylori to gastric epithelium\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJan et al., Commun Biol 3(1):120 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/toxins11110618\" rel=\"noopener\" target=\"_blank\"\u003eCagA Effector Protein in Helicobacter pylori -Infected Human Gastric Epithelium in Vivo: From Bacterial Core and Adhesion\/Injection Clusters to Host Cell Proteasome-Rich Cytosol\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Toxins (Basel) 11(11):E618 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1080\/15548627.2018.1515530\" rel=\"noopener\" target=\"_blank\"\u003eCAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTsugawa et al., Autophagy 15(2):242-258 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms19071826\" rel=\"noopener\" target=\"_blank\"\u003eUnusual Manifestation of Live Staphylococcus saprophyticus, Corynebacterium urinapleomorphum , and Helicobacter pylori in the Gallbladder with Cholecystitis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBackert et al., Int J Mol Sci 19(7):E1826 (2018).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/cdd.2017.89\" rel=\"noopener\" target=\"_blank\"\u003ePathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLim et al., Cell Death Differ 24(9):1621-1631 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1039\/c6sc00889e\" rel=\"noopener\" target=\"_blank\"\u003eMetabolic labelling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJan et al., Chem Sci 7(9):6208-6216 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1004621\" rel=\"noopener\" target=\"_blank\"\u003eA specific A\/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZhang et al., PLoS Pathog 11(2):e1004621 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0096488\" rel=\"noopener\" target=\"_blank\"\u003eSystematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLind et al., PLoS One 9(5):e96488 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0056291\" rel=\"noopener\" target=\"_blank\"\u003ePresence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePapadakos et al., PLoS One 8(2):e56291 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02811.x\" rel=\"noopener\" target=\"_blank\"\u003eCagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSicinschi et al., Clin Microbiol Infect 16(4):369-378 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jcm.02330-08\" rel=\"noopener\" target=\"_blank\"\u003ePolymorphism in the CagA EPIYA motif impacts development of gastric cancer\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJones et al., J Clin Microbiol 47(4):959-968 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.00365-08\" rel=\"noopener\" target=\"_blank\"\u003eCholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLai et al., Infect Immun 76(7):3293-3303 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.7326\/0003-4819-140-9-200405040-00028\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori and idiopathic thrombocytopenic purpura\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eFranceschi et al., Annals of Internal Medicine 140(9):766-767 (2004).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.72.2.1043-1056.2004\" rel=\"noopener\" target=\"_blank\"\u003eFunctional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBackert et al., Infect Immun 72(2):1043-1056 (2004).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1086\/368133\" rel=\"noopener\" target=\"_blank\"\u003eIntracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSemino-Mora et al., J Infect Dis 187(8):1165-1177 (2003).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.96.25.14559\" rel=\"noopener\" target=\"_blank\"\u003eAltered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSegal et al., Proc Natl Acad Sci U S A 96(25):14559-14564 (1999).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5001_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878642478,"sku":"HPM-5001-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5001-100ug.png?v=1788008425","url":"https:\/\/www.australbiologicals.com\/products\/hpm-5001","provider":"Austral Biologicals","version":"1.0","type":"link"}